The present study employs a data review on the presence and aggregation of oxytetracycline (OTC) and resistance (AMR) bacteria in wastewater treatment plants (WWTPs), and the distribution of the contaminated effluent with the aid of shallow and deep ocean currents. The study aims to determine the fate of OTC and AMR bacteria in seafood, and demonstrate a relationship between AMR levels and human health. This review includes (1) OTC, (2) AMR bacteria, (3) heavy metals in aquatic environments, and their relationship. Few publications describe OCT in surface waters. Although OTC and other tetracyclines were found in 10 countries in relatively low concentrations, the continuous water mass movement poses a contamination risk for mariculture and aquaculture. There are 10 locations showing AMR bacteria in treated and untreated hospital effluent. Special effort was made to define the geography distribution of OTC, AMR bacteria, and heavy metals detected in WWTPs to show the likely dissemination in an aquatic environment. The presence of OTC in surface waters in Asia, USA, and Europe can potentially impact seafood globally with the aid of ocean currents. Moreover, low concentrations of heavy metals exert environmental pressure and contribute to AMR dissemination. Recommended solutions are (1) quantitative analysis of OTC, heavy metals, and AMR bacteria to define their main sources; (2) employing effective technologies in urban and industrial wastewater treatment; and (3) selecting appropriate modelling from Global Ocean Observing System to predict the OTC, heavy metals, and AMR bacteria distribution.

Sleep deficiency is now considered an emerging global epidemic associated with many serious health problems, and a major cause of financial and social burdens. Sleep and mental health are closely connected, further exacerbating the negative impact of sleep deficiency on overall health and well-being. A major drawback of conventional treatments is the wide range of undesirable side-effects typically associated with benzodiazepines and antidepressants, which can be more debilitating than the initial disorder. It is therefore valuable to explore the efficiency of other remedies for complementarity and synergism with existing conventional treatments, leading to possible reduction in undesirable side-effects. This review explores the relevance of microalgae bioactives as a sustainable source of valuable phytochemicals that can contribute positively to mood and sleep disorders. Microalgae species producing these compounds are also catalogued, thus creating a useful reference of the state of the art for further exploration of this proposed approach. While we highlight possibilities awaiting investigation, we also identify the associated issues, including minimum dose for therapeutic effect, bioavailability, possible interactions with conventional treatments and the ability to cross the blood brain barrier. We conclude that physical and biological functionalization of microalgae bioactives can have potential in overcoming some of these challenges.